Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
about
Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyNovel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat modelPeripartum cardiomyopathy: A puzzle closer to solution.Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.Autoantibodies and cardiovascular dysfunction: cause or consequence?Relationship between the autoantibody and expression of β3-adrenoceptor in lung and heart.Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbitAptamer Selection Technology and Recent Advances.Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy?MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionNeutralization of anticitrullinated protein antibodies in rheumatoid arthritis - a way to go?The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptors.Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.Cardiac Autoimmunity: Myocarditis.Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathyTargeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology.Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats.
P2860
Q27000434-6C78289F-F240-4A85-AFA7-4361C94B6BBEQ27315858-FCE82D6F-3E43-4D0D-95CB-7DC8BA44995AQ33358118-16CB2255-0F0F-4D66-882C-59C07B3BFB36Q34315311-91ABAE7A-12F1-4C77-9660-1B4A51FF263FQ34473885-44931CD5-EAFD-41C4-AEC1-F211EBFE2536Q34828071-E285F29D-37AB-4378-B857-E57D1EBA604CQ35175458-0385CC5B-E0FF-46FB-86C9-969814562D53Q36256736-87AA352B-8488-4630-9207-C145D9E932D6Q36744349-AE46FB11-2F83-4EF7-AC8C-0909624D056CQ37690123-E9300252-80F8-4F80-8AA9-DC250534C47EQ37973384-3AE3621B-1F08-4C86-B884-8BC926894E68Q38160926-BB57849D-497F-48A9-93C2-227CD07B4CBEQ38162971-36B17E0A-2D11-44BD-B85E-D5F2EEFB59BFQ38207936-74A60F67-F47B-47E7-8173-2FA36CC3D458Q40138726-2B515D67-90EA-4114-A8BE-1AF11B5B4FC0Q40468778-307308B1-0C35-487A-AF29-EF1981F4A8EFQ41223452-2CEB561B-0732-4595-B624-F58E5660673EQ41621802-755A2D3D-63D6-4926-9C06-C7B190686983Q48073010-2404D311-C401-4684-8C12-687D959EEBE6Q48924237-6759655E-C600-42AC-AF42-EA1C52473C79Q50099198-BB8973B2-07A6-4D58-ACBE-C60C4F61950FQ51740847-9D33D67A-BF26-4A51-B3FA-413DC6DE4E2C
P2860
Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@en
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@nl
type
label
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@en
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@nl
prefLabel
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@en
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@nl
P2093
P1433
P1476
Aptamer neutralization of beta ...... atients with cardiomyopathies.
@en
P2093
Andreas Kage
Annekathrin Haberland
Claudia Dahmen
Ingolf Schimke
P304
P356
10.1161/CIRCRESAHA.111.253849
P577
2011-08-25T00:00:00Z